<DOC>
	<DOCNO>NCT01560273</DOCNO>
	<brief_summary>The purpose clinical investigation evaluate clinical outcome subject spondylolisthesis undergo posterolateral fusion ( PLF ) surgery utilize Aspen™ Spinous Process Fixation System . The Aspen™ device evaluate use Oswestry Disability Index ( ODI ) improvement success fusion .</brief_summary>
	<brief_title>Aspen Spinous Process Fixation System Use PLF Patients With Spondylolisthesis</brief_title>
	<detailed_description>Evaluate clinical outcome subject spondylolisthesis undergo posterolateral fusion ( PLF ) surgery utilize Aspen™ Spinous Process Fixation System . The Aspen™ device evaluate use Oswestry Disability Index ( ODI ) improvement success fusion .</detailed_description>
	<mesh_term>Spondylolisthesis</mesh_term>
	<criteria>Age 50 old Diagnosis mild segmental instability stand radiography lateral film define degenerative spondylolisthesis ≤ 4mm dynamic imaging ( i.e. , flexion/extension ) Scheduled elective singlelevel posterior decompression posterolateral fusion use AspenTM spinous process fixation system Oswestry Disability Index ( ODI ) v 2.1 score &gt; 30 % Failed least 3 month conservative care ( nonsurgical ) OR clinical sign neurological deterioration Signed Informed Consent Form Preoperative Marked degenerative spondylolisthesis ( &gt; 4mm ) Lesions require surgery involve two level Prior surgery index level adjacent level Prior spinal fusion surgery Isthmic lytic spondylolisthesis Incompetent miss posterior arch affect level ( e.g . complete laminectomy , par defect ) Requires complete laminectomy level surgery Facet joint implant level absent fracture Vertebral body compromise acute fracture implant level Body mass Index ( BMI ) ≥ 35 Known allergy titanium Osteoporosis : SCORE ( Simple Calculated Osteoporosis Risk Estimation ) use screen subject require DEXA . Subjects Tscore &lt; 2.5 exclude Paget 's disease , osteomalacia , metabolic bone disease Use medication drug know potentially interfere bone/soft tissue healing ( e.g . chronic systemic steroid ) Planned use additional segmental fixation ( eg . facet screw , anterior/lateral plating , anchor cage ) Use Bone Morphogenetic Protein ( BMP ) * Unlikely comply followup evaluation schedule In opinion Investigator , Subject history chemical substance dependency significant psychosocial disturbance may impact outcome study participation Active participation clinical trial another drug device Active systemic infection health condition would preclude surgery History invasive malignancy , except subject receive treatment display clinical sign symptom least five year Pregnant plan become pregnant study participation Involvement active litigation relate back problem time screen Direct involvement execution protocol Preexisting condition could interfere evaluation outcome measure ( e.g . musculoskeletal , neuromuscular , etc . ) Intraoperative Exclusion Intraoperative visualization &gt; 4mm spondylolisthesis previously note radiographically Any change surgical procedure violate inclusion/exclusion criterion . ( eg . switch double level procedure ; place pedicle screw posterior fixation ) .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>